{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:46:43Z","timestamp":1759481203269},"reference-count":9,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":11064,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1977,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Twenty\u2010three patients with bone disease and chronic renal failure were treated for periods of 4\u201328 months with l\u03b1\u2010hydroxyvitamin D<jats:sub>3<\/jats:sub> (1\u03b1\u2010OHD<jats:sub>3<\/jats:sub>). Improvements in bone histology were consistently seen in patients with features both of osteitis fibrosa and osteomalacia but were not invariably observed in patients with osteitis fibrosa or osteomalacia alone (37 and 50% improved respectively). Several factors influencing the outcome of treatment were assessed on the basis of histological responses in bone. A low level of plasma calcium before treatment, rather than the dose of l\u03b1\u2010OHD<jats:sub>3<\/jats:sub> tolerated, was the major detectable factor which favourably affected the histological outcome. Other factors examined, including initial plasma concentrations of phosphate, immunoreactive parathyroid hormone and alkaline phosphatase, and treatment with haemodialysis or dietary supplements of calcium did not apparently influence the response.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1977.tb03362.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T13:33:50Z","timestamp":1205760830000},"source":"Crossref","is-referenced-by-count":3,"title":["FACTORS INFLUENCING THE RESPONSE TO l\u03b1\u2010HYDROXYVITAMIN D<sub>3<\/sub> IN PATIENTS WITH RENAL BONE DISEASE"],"prefix":"10.1111","volume":"7","author":[{"given":"J. A.","family":"KANIS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G. G.","family":"RUSSELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"NAIK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"EARNSHAW","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"SMITH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"HEYNEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"WOODS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5924.150"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1515\/9783112327203-114","volume-title":"Vitamin D: Biochemical. Chemical and Clinical Aspects Related to Calcium Metabolism","author":"COBURN J.W.","year":"1977"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb03823.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1515\/9783112327203-116","volume-title":"Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism","author":"KANIS J.A.","year":"1977"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197705122961901"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6028.142"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92197-1"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90061-1"},{"key":"e_1_2_1_10_1","first-page":"189","article-title":"l\u03b1\u2010hydroxycholecdciferol in haemodialysis renal osteodystrophy. Adverse effects of anti\u2010convulsant therapy","volume":"5","author":"PIERIDES A.M.","year":"1976","journal-title":"Clinical Nephrology"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1977.tb03362.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1977.tb03362.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T11:31:02Z","timestamp":1695727862000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1977.tb03362.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,12]]},"references-count":9,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1977,12]]}},"alternative-id":["10.1111\/j.1365-2265.1977.tb03362.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1977.tb03362.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,12]]}}}